1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global Malaria Partnering 2010-2015

Global Malaria Partnering 2010-2015

  • July 2015
  • -
  • Currentpartnering
  • -
  • 150 pages

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service.

The Malaria Partnering 2010-2015 report provides understanding and access to the malaria partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in malaria partnering deals
Top malaria deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

The Malaria Partnering 2010-2015 provides understanding and access to the malaria partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of malaria partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors malaria technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This data driven report contains over 90 links to online copies of actual malaria deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of malaria partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 3 provides an overview of the average deal terms since 2010. The chapter includes deals with a stage of development announced by headline value, upfront value, milestone value and royalty rate. Numerous tables outline financial trends.

Chapter 4 provides an overview of the most active dealmakers, top dealmakers by value, active big pharma and big biotech dealmakers including contract documents where available.

Chapter 5 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of malaria technologies and products.

Report scope

Malaria Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to malaria trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:

Trends in malaria dealmaking in the biopharma industry since 2010
Access to summary headline, upfront, milestone and royalty data
Access to over 90 malaria deals
The leading malaria deals by value since 2010

In Malaria Partnering 2010-2015, the available deals are listed by:

Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.Malaria Partnering 2010-2015 provides the reader with the following key benefits:

In-depth understanding of malaria deal trends since 2010
Access to summary headline, upfront, milestone and royalty data
Comprehensive access to over 90 actual malaria deals entered into by the world’s biopharma companies since 2010
Insight into key deal terms included in contracts, where disclosed
Understand the key deal terms companies have agreed in deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Table Of Contents

Global Malaria Partnering 2010-2015
Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in malaria partnering

2.1. Introduction
2.2. Malaria partnering over the years
2.3. Malaria partnering by deal type
2.4. Malaria partnering industry sector
2.5. Malaria partnering by stage of development
2.6. Malaria partnering by technology type

Chapter 3 - Average deal terms for malaria

3.1 Introduction
3.2 Average deal terms for malaria
3.3 Malaria headline values with median calculation
3.4 Malaria upfront values with median calculation
3.5 Malaria milestone values with median calculation
3.6 Malaria royalty rates with median calculation

Chapter 4 - Active malaria dealmakers

4.1. Introduction
4.2 Most active malaria dealmakers
4.3. Top malaria deals by value
4.4 Big pharma deal activity
4.5 Big biotech deal activity

Chapter 5 - Malaria dealmaking directory

5.1. Introduction
5.2. Company A-Z
5.3. By deal type
5.4. By industry sector
5.5. By stage of development
5.6. By technology type

Chapter 6 - Partnering resource center

6.1. Online partnering
6.2. Partnering events
6.3. Further reading on dealmaking

Appendices

Appendix 1 - Deal type definitions

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering
Order Form - Reports
Order Form - Subscription Access Products

Table of figures

Figure 1: Malaria partnering since 2010
Figure 2: Malaria dealmaking activity- 2010 to 2015
Figure 3: Malaria partnering by deal type since 2010
Figure 4: Malaria partnering by industry sector since 2010
Figure 5: Malaria partnering by stage of development since 2010
Figure 6: Malaria partnering by technology type since 2010
Figure 7: Malaria deals with a headline value
Figure 8: Malaria deals with upfront payment values
Figure 9: Malaria deals with milestone payments
Figure 10: Malaria deals with royalty rates, %
Figure 11: Top malaria deals by value since 2010
Figure 12: Big pharma - top 50 - malaria deals 2010 to 2015
Figure 13: Big pharma malaria deal frequency - 2010 to 2015
Figure 14: Big biotech - top 50 - malaria deals 2010 to 2015
Figure 15: Big biotech malaria deal frequency - 2010 to 2015
Figure 16: Online partnering resources
Figure 17: Forthcoming partnering events
Figure 18: Deal type definitions

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Influenza Statistics in India

  • January 2017
    6 pages
  • Influenza  

    Vaccine  

    Diabetes  

  • India  

    United States  

View report >

Influenza Statistics in Ireland, Weekly Update

  • January 2017
    11 pages
  • Influenza  

  • Ireland  

    Europe  

View report >

AIDS Statistics and Cardiovascular Disease Statistics in Kenya

  • January 2017
    197 pages
  • AIDS  

    Infectious Dise...  

    Cardiovascular ...  

  • Kenya  

    Africa  

View report >

Related Market Segments :

Infectious Disease

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.